Alexion Pharmaceuticals: Revising My Valuation (NASDAQ:ALXN) | Seeking Alpha
Justice Department alleges more drug copay kickbacks
Alexion Pharmaceuticals - Drug Discovery and Development
Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)
AstraZeneca drug added in Alexion acquisition falls short in pivotal ALS trial - MedCity News
Alexion trials rare disease drug Ultomiris in severe COVID-19 cases | Pharmaphorum
Alexion tests drug for possible COVID-19 treatment | New Haven BIZ
Alexion Pharma's Bloated Blockbuster Deal Still Haunts - TheStreet
Alexion Pharmaceuticals Marketed Drugs - GlobalData
AstraZeneca to acquire Alexion for $39B - Drug Discovery and Development
How pharmaceutical company Alexion set the price of the world's most expensive drug | CBC News
Alexion's Soliris wins FDA 'orphan' nod | Hartford Business Journal
Alexion, Vertex rare disease drugs fare well in new rare disease drug report - Boston Business Journal
Will 2016 Be Alexion Pharmaceuticals Inc.'s Best Year Yet? | The Motley Fool
Medicines | Alexion
New Alexion rare-disease drug wins FDA approval | New Haven BIZ
When the Patient Is a Gold Mine: The Trouble With Rare-Disease Drugs - Bloomberg
Five years later, Alexion sets aside $25M to resolve SEC's foreign bribery probe | Fierce Pharma
Handok's 2023 turnover to drop sharply as AZ retrieves sales rights < Pharma < Article - KBR
Eculizumab - Wikipedia
Alexion to begin Phase 3 testing on drug to treat ALS
Canadian Drug Watchdog Orders Alexion to Lower Price of Soliris, Refund Overcharges - Global Genes
NICE rejects second Alexion ultra-rare disease drug | Pharmaphorum
The Innovative Medicines Fund: A catalyst to drive access to rare disease treatments? September 2021
Alexion Pharmaceuticals: Patent Resolution Is Too Little Too Late (NASDAQ:ALXN) | Seeking Alpha
MDA Celebrates FDA Approval of Alexion's Ultomiris for Treatment of gMG
Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics™ for Rare Diseases | Business Wire
AstraZeneca + Alexion = Rescue of Both Companies • BioPharma Media
